Amazon appoints FDA’s first FDA Chief Health Informatics Officer to its health team

By Catherine Sturman
Share
It has been announced that Amazon has recently appointed healthcare magnate Taha Kass-Hout to its healthcare team, reportedly named 1492. With extensiv...

It has been announced that Amazon has recently appointed healthcare magnate Taha Kass-Hout to its healthcare team, reportedly named 1492.

With extensive experience across the healthcare sector, Kass-Hout is set to work alongside Babak Parviz to further Amazon’s various projects in this space.

Working as Senior Vice President and Chief Digital Health and Intelligence Officer at Trinity Health up to May last year, Kass-Hout was responsible for setting the vision, strategic direction and overall oversight of data, analytics and digital health initiatives, according to LinkedIn.

Previously, he also worked as FDA’s first Chief Health Informatics Officer for over three years.

See also

Amazon is slowly moving into the healthcare sector, with the launch of its Alexa assistant, which is now harnessed within a number of healthcare initiatives. Additionally, the company’s recent partnership with J.P. Morgan and Berkshire Hathaway highlights the e-commerce giant’s increased interest in healthcare, yet is keeping its own internal operations under wraps.

Nonetheless, the company will face a number of complex hurtles surrounding ongoing regulations, particularly with the security of healthcare data and the need for increased data sharing across a number of healthcare platforms.

Kass-Hout’s work as a Harvard-trained physician and role as Director of Health Informatics Solutions and Operations will become advantageous as Amazon looks to navigate such issues whilst implementating new digital tools. The company is reportedly entering the pharmaceutical distribution sector, and aims to lower healthcare costs for US citizens.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma